erythromycin propionate-n-acetylcysteinate has been researched along with isoxazoles in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boulton, S; Chen, H; Cheng, X; Mei, F; Melacini, G; Ye, N; Zhou, J; Zhu, Y | 1 |
1 other study(ies) available for erythromycin propionate-n-acetylcysteinate and isoxazoles
| Article | Year |
|---|---|
Biochemical and pharmacological characterizations of ESI-09 based EPAC inhibitors: defining the ESI-09 "therapeutic window".
Topics: Acetylcysteine; Animals; Erythromycin; Hydrazones; Isoxazoles; Mice; Mice, Knockout; Structure-Activity Relationship | 2015 |